Preferential Reservoir Seeding in HPV16-Specific CD4-T-Cells During HIV-1 Acute and Chronic Infection

Clicks: 31
ID: 325069
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #246 of 505 articles by views in The Journal of infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 505 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract The anal canal represents the primary site of HIV-1 acquisition in men-who-have-sex-with-men (MSM), while MSM-living-with-HIV (MLWH) have the highest anal cancer incidence. Since HPV16-infection and low-nadir CD4-T-cell counts predict anal cancer risk, we developed an assay to identify and characterize HPV16-specific T-cell responses in MLWH. 40% of acutely and 81% of chronically infected MLWH had HPV16-specific CD4-T-cells, which harbored higher levels of HIV-1 DNA/RNA than non-HPV16-specific CD4-T-cells. T-cell-receptor (TCR) sequencing revealed a less diverse and more restricted TCR-repertoire in HPV16-specific CD4-T-cells. HPV16-specific CD4-T-cells represent an early-established preferential HIV-1 reservoir and a potential novel immunologic correlate of anal cancer-risk in MLWH.
Reference Key
openalex_W7203473566 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal The Journal of infectious diseases
Year 2026
DOI
10.1093/infdis/jiag424
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.